Hugel, Inc.
Industry Group: Pharmaceuticals
Country/Region: South Korea
Identifier: KRX:145020
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 342 out of 911
Universe
Global Universe 9509 out of 16034
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Deciphera Pharmaceuticals, Inc. |
21.2
Medium
|
113 out of 911 |
Beam Therapeutics, Inc. |
26.1
Medium
|
277 out of 911 |
Intellia Therapeutics, Inc. |
26.9
Medium
|
329 out of 911 |
Hugel, Inc. |
27
Medium
|
342 out of 911 |
Shenzhen Kangtai Biological Products Co., Ltd. |
30.3
High
|
545 out of 911 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Hugel, Inc.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Hugel, Inc.'s Management of ESG Material Risk is Average
How do the ESG Risk Ratings work?
Controversy Rating
Highest Controversy level that has impacted Hugel, Inc.'s ESG Risk Rating in the last three years
Highest Controversy Level